372 related articles for article (PubMed ID: 19181781)
1. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.
Iolascon A; De Falco L; Beaumont C
Haematologica; 2009 Mar; 94(3):395-408. PubMed ID: 19181781
[TBL] [Abstract][Full Text] [Related]
2. Inherited microcytic anemias.
Cappellini MD; Russo R; Andolfo I; Iolascon A
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):465-470. PubMed ID: 33275715
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
4. How I Diagnose Non-thalassemic Microcytic Anemias.
Bruno M; De Falco L; Iolascon A
Semin Hematol; 2015 Oct; 52(4):270-8. PubMed ID: 26404439
[TBL] [Abstract][Full Text] [Related]
5. Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis.
Donker AE; Raymakers RA; Vlasveld LT; van Barneveld T; Terink R; Dors N; Brons PP; Knoers NV; Swinkels DW
Blood; 2014 Jun; 123(25):3873-86; quiz 4005. PubMed ID: 24665134
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of the sideroblastic anemias.
Fitzsimons EJ; May A
Curr Opin Hematol; 1996 Mar; 3(2):167-72. PubMed ID: 9372069
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in iron metabolism and iron-related anemia].
Harigae H
Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
[TBL] [Abstract][Full Text] [Related]
8. hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse.
Tian M; Campagna DR; Woodward LS; Justice MJ; Fleming MD
Blood; 2008 Nov; 112(10):4308-13. PubMed ID: 18780836
[TBL] [Abstract][Full Text] [Related]
9. Heme synthesis and hypochromic anemia.
Robinson SH
N Engl J Med; 1969 Mar; 280(11):615. PubMed ID: 5764831
[No Abstract] [Full Text] [Related]
10. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
11. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse.
Ohgami RS; Campagna DR; Antiochos B; Wood EB; Sharp JJ; Barker JE; Fleming MD
Blood; 2005 Nov; 106(10):3625-31. PubMed ID: 15994289
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M; Malcovati L
Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
[TBL] [Abstract][Full Text] [Related]
13. [Iron metabolism in siderosensitive and sideroachrestic anemias. Differential diagnosis of hypochromic microcytic anemia].
Heinrich HC
Med Klin; 1978 Sep; 73(39):1335-42. PubMed ID: 360024
[No Abstract] [Full Text] [Related]
14. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
Ferreira GC
J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
[TBL] [Abstract][Full Text] [Related]
15. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
16. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.
Nakajima O; Okano S; Harada H; Kusaka T; Gao X; Hosoya T; Suzuki N; Takahashi S; Yamamoto M
Genes Cells; 2006 Jun; 11(6):685-700. PubMed ID: 16716198
[TBL] [Abstract][Full Text] [Related]
17. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
18. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
19. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R; Mansouri A; Martelli A; Bayart S; Manceau H; Callebaut I; Moulouel B; Gouya L; Puy H; Kannengiesser C; Karim Z
Mol Genet Metab; 2019 Nov; 128(3):342-351. PubMed ID: 30660387
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial iron metabolism and sideroblastic anemia.
Sheftel AD; Richardson DR; Prchal J; Ponka P
Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
